AstraZeneca Faces Patent Challenge For Best-Selling Drug
Teva has filed an Abbreviated New Drug Application with the Food and Drug Administration (ANDA) with the U.S. Food and Drug Administration to make a 25 mg version of Seroquel.
Seroquel is the Anglo-Swedish company’s best selling drug, with sales accounting for nearly 10% of AstraZeneca’s revenues. In the U.S. alone, the drug generated $1.5...
To view the full article, register now.